Trial-specific Patient Decision Aid (tPDA) of the ImmunoSABR Phase 2
NCT04604470
·
clinicaltrials.gov ↗
UNKNOWN
Status
126
Enrollment
OTHER
Sponsor class
Conditions
NSCLC Stage IV
Lung Cancer
Non Small Cell Lung Cancer
Metastatic Cancer
Interventions
OTHER:
Decision tool
Sponsor
Maastricht University